Analystreport

Trillium Therapeutics Inc (NASDAQ: TRIL) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

Defiance Trillion Dollar Club Index ETF  (TRIL) 
Last defiance trillion dollar club index etf earnings: 5/13 07:00 am Check Earnings Report